生物工程支架市场按应用、产品类型、给药途径、材质、最终用户和地区划分

生物工程支架市场预计在 2026 年达到 57.476 亿美元，预计到 2033 年将达到 99.603 亿美元，2026 年至 2033 年的复合年增长率为 8.7%。

生物工程支架由短而细的金属或塑胶管组成，用于治疗阻塞的动脉。它们适用于患有各种心血管疾病的患者，包括心臟疾病和缺血性心臟疾病。市面上有多种生物工程支架可用于治疗各种疾病，包括冠状动脉疾病、周边动脉疾病、颈动脉疾病、肾腹部主动脉血管瘤主动脉瘤和胸主动脉瘤。

市场动态

肾臟疾病盛行率的不断上升是推动生物工程支架市场成长的主要因素。根据美国心臟协会理事会统计，2015年心血管疾病是全球首要死因，每年造成超过1,790万人死亡，预计2030年将超过2,360万人。根据同一资讯来源统计，2015年美国约有836,546人死于心血管疾病，约占总死亡人数的三分之一。

此外，市场上的主要企业正致力于采取各种策略，例如推出新产品、获得产品核准以及建立合作伙伴关係和开展合作，以巩固其市场地位。例如，2017年5月，Medtronic获得美国食品药物管理局（FDA）的核准，推出了Resolute Onyx 4.5毫米和5毫米药物释放型支架。该产品已证实了Resolute Integrity支架的临床性能和卓越的输送性能。该产品旨在用于治疗美国冠状动脉疾病患者。

然而，心臟疾病治疗领域替代品的出现、产品召回和故障，以及产品类型核准的严格监管，预计将阻碍市场成长。例如，2017年11月，雅培公司对其可吸收血管支架（BVS）系统（一种可吸收冠状动脉药物释放型洗脱支架）发布了一级医疗器械召回令，原因是与使用Xience金属药物释放型支架治疗的患者相比，使用该系统的患者发生严重不利事件（如心肌梗塞和支架血栓症）的机率更高。

本次调查的主要特点

• 本报告以 2017 年为基准年，对生物工程支架市场进行了详细分析，并提供了预测期（2018-2026 年）的市场规模和复合年增长率。
• 我们将重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本报告根据以下参数对全球生物工程支架市场的主要参与者进行了分析：公司概况、财务业绩、产品类型组合、市场占有率、分销策略、主要发展、战略和未来计划。
• 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
• 这份全球生物工程支架市场报告针对该行业的各个相关人员，例如投资者、供应商、产品类型製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过各种用于分析生物工程支架市场的策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场范围

• 报告概述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、监管与趋势分析

• 市场动态
  • 司机
  • 抑制因素
  • 市场机会
• 市场趋势
• 影响分析
• 主要亮点
• PEST分析
• 波特分析
• 併购
• 流行病学

4. 2026-2033年全球生物工程支架市场（依应用领域划分）

• 冠状动脉疾病
• 周边动脉疾病
• 颈动脉疾病
• 肾动脉狭窄
• 腹部主动脉血管瘤
• 胸主动脉瘤
• 其他的

5. 2026-2033年全球生物工程支架市场（依产品类型划分）

• 药物释放型支架
• 生物可吸收支架
• 药物释放型球囊

6. 2026-2033年全球生物工程支架市场（以输送方式划分）

• 球囊扩张型支架
• 自动扩张型支架

7. 2026-2033年全球生物工程支架市场（依材料类型）

• 金属底座
• 聚合物基

8. 2026-2033年全球生物工程支架市场（依最终用户划分）

• 医院和心臟中心
• 门诊手术中心
• 其他的

9. 2026-2033年全球生物工程支架市场（按地区划分）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太地区的其他国家
• 中东
  • GCC
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 中非
  • 北非

第十章 竞争格局

• 热图分析
• 市占率分析
• 公司简介
  • Medtronic, plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • BIOTRONIK SE &Co. KG
  • B. Braun Melsungen AG
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • STENTYS SA
  • Meril Life Sciences Pvt. Ltd.
  • Vascular Concepts
  • WL Gore and Associates
  • CR Bard
  • Endologix, Inc.
  • Lombard Medical Technologies
  • Translumina GmbH
  • JOTEC GmbH

第十一章各节

• 参考
• 调查方法

Bio-engineered Stent Market is estimated to be valued at USD 5,747.60 Mn in 2026 and is expected to reach USD 9,960.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2033.

Bio-engineered stents consist of short narrow metal or plastic tube, which is used to treat blocked arteries. It is used by patients who are suffering from different types of cardiovascular diseases such as coronary heart disease and ischemic heart disease. Different types of bio-engineered stent are available in market for various diseases such as coronary artery disease, peripheral arterial disease, carotid artery disease, renal artery stenosis, abdominal aortic aneurysm, thoracic aortic aneurysm among others.

Market Dynamics

Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same source, cardiovascular diseases accounted for around 836,546 deaths in the U.S. in 2015, which accounted for around 1 in every 3 deaths.

Moreover, key players in the market are focused on adopting various strategies such as new Product Type launch and approvals and partnerships and collaborations to increase their foothold in the market. For instance, in May 2017, Medtronic plc., received the U.S. Food and Drug Administration (FDA) approval and Resolute Onyx, 4.5 MM and 5 mm sizes Drug-Eluting Stent. This device has proven clinical performance and superior deliverability of the Resolute Integrity. This device is intended to treat people with coronary artery disease in the U.S.

However, availability of alternatives for the treatment of cardiac diseases, Product Type recalls and failure, and stringent regulations for Product Type approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, an absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent.

Key features of the study

• This report provides in-depth analysis of the bio-engineered stents market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global bio-engineered stents market based on the following parameters - company overview, financial performance, Product Type portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and Jotec GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Bio-engineered stents market report caters to various stakeholders in this industry including investors, suppliers, Product Type manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bio-engineered stents market

Market Segmentation

• By Application Type
  • Coronary artery disease
  • Peripheral arterial disease
  • Carotid Artery Disease
  • Renal Artery Stenosis
  • Abdominal Aortic Aneurysm
  • Thoracic Aortic Aneurysm
  • Others
• By Product Type
  • Drug-eluting Stents
  • Bioabsorbable Stents
  • Drug-eluting balloons
• By Mode of Delivery
  • Balloon-expandable Stents
  • Self-expanding Stents
• By Material Type
  • Metal-based
  • Polymer-based
• By End User
  • Hospitals & Cardiac Centers
  • Ambulatory Surgical Centers
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • Medtronic, plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Braun Melsungen AG
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Stentys Sao
  • Meril Life Sciences Pvt. Ltd
  • Vascular Concepts
  • L. Gore and Associates
  • R. Bard
  • Endologix, Inc.
  • Lombard Medical Technologies
  • Translumina GmbH
  • JOTEC GmbH

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Application Type
  • Market Snippet, By Product Type
  • Market Snippet, By Material Type
  • Market Snippet, By Mode of Delivery
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Market Trends
• Impact Analysis
• Key Highlights
• PEST Analysis
• PORTER's Analysis
• Mergers and Acquisitions
• Epidemiology

4. Global Bio-engineered Stent Market, By Application Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026- 2033
  • Segment Trends
• Coronary artery disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Peripheral arterial disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Carotid Artery Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Renal Artery Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Abdominal Aortic Aneurysm
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Thoracic Aortic Aneurysm
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Bio-engineered Stent Market, By Product Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026- 2033
  • Segment Trends
• Drug-eluting Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Bioabsorbable Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Drug-eluting balloons
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Bio-engineered Stent Market, By Mode of Delivery, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026- 2033
  • Segment Trends
• Balloon-expandable Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Self-expanding Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Bio-engineered Stent Market, By Material Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026- 2033
  • Segment Trends
• Metal-based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Polymer-based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

8. Global Bio-engineered Stent Market, By End User, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026- 2033
  • Segment Trends
• Hospitals & Cardiac Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

9. Global Bio-engineered Stent Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2033
• North America
  • Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
• Middle East
  • Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
• Company Profiles
  • Medtronic, plc.
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Boston Scientific Corporation
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Abbott Laboratories
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • BIOTRONIK SE & Co. KG
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • B. Braun Melsungen AG
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Terumo Corporation
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • MicroPort Scientific Corporation
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • STENTYS SA
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Meril Life Sciences Pvt. Ltd.
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Vascular Concepts
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • W. L. Gore and Associates
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • C. R. Bard
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Endologix, Inc.
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Lombard Medical Technologies
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Translumina GmbH
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • JOTEC GmbH
    • Company Overview
    • Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Analyst Views

11. Section

• References
• Research Methodology
• About Us and Sales Contact